Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy
Respiratory Care · 2025
DOI: 10.1089/respcare.12494 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Respiratory Care, 2025. Verfasst von Rahul Costa-Pinto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Drs. Costa-Pinto, Massarany, Xu and Prof. Bellomo are affiliated with Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia. Hauptthemen laut MEDLINE: Adrenal Cortex Hormones, COVID-19, COVID-19 Drug Treatment, Dexamethasone. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Rebound hypoxemia may occur after cessation of corticosteroid therapy for COVID-19 pneumonitis. We aimed to determine the incidence of this phenomenon in mechanically ventilated patients with COVID-19 completing corticosteroid therapy.
Methods
We conducted a retrospective observational cohort study across 2 tertiary ICUs from September to December 2021. We included all adult patients receiving invasive mechanical ventilation on completion of a 10-day course of dexamethasone for COVID pneumonitis. Our primary outcome was change in PaO2/FIO2 ratio in the 7 days following cessation of dexamethasone. Secondary outcomes included duration of ventilation, frequency of corticosteroid recommencement, and mortality.
Results
We studied 88 subjects. Median age was 61 years (interquartile range [IQR] 51-67), and median duration of mechanical ventilation was 14 days (IQR 11-26). On completion of dexamethasone, 62 subjects (70%) remained off corticosteroid therapy for the subsequent 7 days. Of these, 63% (n = 20) had a stable PaO2/FIO2 ratio on day 7 (mean change 197 ± 42 mm Hg to 258 ± 83 mm Hg). Subjects who had a reduction in PaO2/FIO2 ratio >20 mm Hg by day 7 (mean change 214 ± 68 mm Hg to 152 ± 78 mm Hg) were more likely to die in hospital (P < .001). These subjects had a higher C-reactive protein level at time of steroid cessation (204 ± 87 mg/L, P = .17), which remained persistently elevated (206 ± 89 mg/L, P = .01) on day 7. The 30% of subjects who recommenced steroids required a longer duration of ventilation (13.5 vs 24.5 d, P = .002) but showed no differences in ICU mortality (19% vs 27%, P = .43).
Conclusions
Rebound hypoxemia and steroid recommencement were common occurrences in mechanically ventilated subjects with COVID-19. Rebound hypoxemia was associated with higher mortality. Steroid recommencement was associated with longer duration of mechanical ventilation but no significant difference in mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drs. Costa-Pinto, Massarany, Xu and Prof. Bellomo are affiliated with Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia.
- Drs. Costa-Pinto, Rotherham and Prof. Bellomo are affiliated with Department of Critical Care, Department of Medicine, the University of Melbourne, Parkville, Victoria, Australia.
- Drs. Rotherham, Perera, Chen and Prof. Bellomo are affiliated with Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- Dr. O'Brien is affiliated with Department of Anaesthesia, Austin Hospital, Heidelberg, Victoria, Australia.
- Prof. Bellomo is affiliated with Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- Prof. Bellomo was affiliated with Data Analytics Research and Evaluation Centre, The University of Melbourne and Austin Hospital, Melbourne, Australia.
Zitieren
APA
Costa-Pinto, R., Rotherham, H., O'Brien, Z., Perera, P., Chen, V., Massarany, C., Xu, B., & Bellomo, R. (2025). Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy. Respiratory Care. https://doi.org/10.1089/respcare.12494
Vancouver
Costa-Pinto R, Rotherham H, O'Brien Z, Perera P, Chen V, Massarany C, et al. Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy. Respiratory Care. 2025. doi:10.1089/respcare.12494
BibTeX
@article{CostaPinto2025,
author = {Costa-Pinto, Rahul and Rotherham, Hannah and O'Brien, Zachary and Perera, Padeepa and Chen, Vicky and Massarany, Christopher and Xu, Brett and Bellomo, Rinaldo},
title = {Rebound Hypoxemia in Mechanically Ventilated Patients With COVID-19 Completing a Standard 10-Day Course of Corticosteroid Therapy},
journal = {Respiratory Care},
year = {2025},
doi = {10.1089/respcare.12494}
}
EUVIMED